SEC Form 4 research
| Issuer | Viridian Therapeutics, Inc.\DE |
|---|---|
| Tickers | MGEN, VRDN, SGNL |
| Reporting owners | 59 |
| Officers and directors | 15 |
| Last public filing | 2026-08-21 |
| Available | Trade date | Reporting owners | Code | Shares | Price | Reported value |
|---|---|---|---|---|---|---|
| 2026-08-20 | 2026-08-19 | Tousignant Jennifer | S | 10,000 | $24.5 | Not reported |
| 2026-08-20 | 2026-08-19 | Tousignant Jennifer | S | 4,212 | $24.5 | Not reported |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.